The Role of Disease Activity as a Determinant of Central Sensitivity and Body Awareness in Fibromyalgia Patients: A Cross-Sectional Study
Purpose: The present study aimed to identify the influence of disease activity on central sensitization (CS) and body awareness in fibromyalgia syndrome (FMS) patients. Materials and Methods: Forty-five patients with FMS (mean age: 45.9 (6.9) years, median disease duration: 3 (2-6) years) were pa...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Kirsehir Ahi Evran University
2025-04-01
|
| Series: | Ahi Evran Medical Journal |
| Subjects: | |
| Online Access: | https://dergipark.org.tr/tr/download/article-file/4144550 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849721745922064384 |
|---|---|
| author | Yasemin Mirza Adem Küçük |
| author_facet | Yasemin Mirza Adem Küçük |
| author_sort | Yasemin Mirza |
| collection | DOAJ |
| description | Purpose: The present study aimed to identify the influence of disease activity on central sensitization (CS) and body awareness in fibromyalgia syndrome (FMS) patients.
Materials and Methods: Forty-five patients with FMS (mean age: 45.9 (6.9) years, median disease duration: 3 (2-6) years) were participated this cross-sectional study. Disease activity was assessed using the Fibromyalgia Impact Questionnaire (FIQ) and higher score was considered high disease activity. The Central Sensitization Inventory (CSI) was performed for central sensitivity. Body awareness levels were evaluated with the Body Awareness Questionnaire (BAQ). Visual Analogue Scale (VAS) was used to identify pain severity. Simple linear regression analyses were used to determine which independent variables could explain disease activity.
Results: The mean FIQ and BAQ were 53.4 and 90 points, respectively. The median VAS and CSI were 8 cm and 52 point, respectively. The CS is positive in 82.2% of all patients. FIQ was moderately correlated with the VAS score (r=0.445, R2=0.198, p=0.002) and is highly correlated with CSI (r=0.539, R2=0.291, p<0.001). There was no significant correlation between FIQ and BAQ (p=0.791). The results of the simple linear regression analysis presented that VAS explained 19.8% of the the disease activity. FIQ (r=0.445, p=0.002) significantly predicted pain severity. Additionally, The CSI explained 29.1% of the disease activity and FIQ (r=0.539, p<0.001) significantly predicted CS.
Conclusion: High disease activity negatively impacts CS and body awareness in FMS patients. Clinicians should consider a multimodal biopsychosocial perspective in addition to routine treatments in the management of patients with high disease activity. |
| format | Article |
| id | doaj-art-286bb1456c27432e8087bcdcdc5e6e82 |
| institution | DOAJ |
| issn | 2619-9203 |
| language | English |
| publishDate | 2025-04-01 |
| publisher | Kirsehir Ahi Evran University |
| record_format | Article |
| series | Ahi Evran Medical Journal |
| spelling | doaj-art-286bb1456c27432e8087bcdcdc5e6e822025-08-20T03:11:33ZengKirsehir Ahi Evran UniversityAhi Evran Medical Journal2619-92032025-04-0191303610.46332/aemj.1533118The Role of Disease Activity as a Determinant of Central Sensitivity and Body Awareness in Fibromyalgia Patients: A Cross-Sectional StudyYasemin Mirza0https://orcid.org/0000-0002-4367-2355Adem Küçük1https://orcid.org/0000-0001-8028-1671NECMETTİN ERBAKAN ÜNİVERSİTESİNECMETTIN ERBAKAN UNIVERSITYPurpose: The present study aimed to identify the influence of disease activity on central sensitization (CS) and body awareness in fibromyalgia syndrome (FMS) patients. Materials and Methods: Forty-five patients with FMS (mean age: 45.9 (6.9) years, median disease duration: 3 (2-6) years) were participated this cross-sectional study. Disease activity was assessed using the Fibromyalgia Impact Questionnaire (FIQ) and higher score was considered high disease activity. The Central Sensitization Inventory (CSI) was performed for central sensitivity. Body awareness levels were evaluated with the Body Awareness Questionnaire (BAQ). Visual Analogue Scale (VAS) was used to identify pain severity. Simple linear regression analyses were used to determine which independent variables could explain disease activity. Results: The mean FIQ and BAQ were 53.4 and 90 points, respectively. The median VAS and CSI were 8 cm and 52 point, respectively. The CS is positive in 82.2% of all patients. FIQ was moderately correlated with the VAS score (r=0.445, R2=0.198, p=0.002) and is highly correlated with CSI (r=0.539, R2=0.291, p<0.001). There was no significant correlation between FIQ and BAQ (p=0.791). The results of the simple linear regression analysis presented that VAS explained 19.8% of the the disease activity. FIQ (r=0.445, p=0.002) significantly predicted pain severity. Additionally, The CSI explained 29.1% of the disease activity and FIQ (r=0.539, p<0.001) significantly predicted CS. Conclusion: High disease activity negatively impacts CS and body awareness in FMS patients. Clinicians should consider a multimodal biopsychosocial perspective in addition to routine treatments in the management of patients with high disease activity.https://dergipark.org.tr/tr/download/article-file/4144550body awarenesscentral sensitizationfibromyalgia syndromedisease activity |
| spellingShingle | Yasemin Mirza Adem Küçük The Role of Disease Activity as a Determinant of Central Sensitivity and Body Awareness in Fibromyalgia Patients: A Cross-Sectional Study Ahi Evran Medical Journal body awareness central sensitization fibromyalgia syndrome disease activity |
| title | The Role of Disease Activity as a Determinant of Central Sensitivity and Body Awareness in Fibromyalgia Patients: A Cross-Sectional Study |
| title_full | The Role of Disease Activity as a Determinant of Central Sensitivity and Body Awareness in Fibromyalgia Patients: A Cross-Sectional Study |
| title_fullStr | The Role of Disease Activity as a Determinant of Central Sensitivity and Body Awareness in Fibromyalgia Patients: A Cross-Sectional Study |
| title_full_unstemmed | The Role of Disease Activity as a Determinant of Central Sensitivity and Body Awareness in Fibromyalgia Patients: A Cross-Sectional Study |
| title_short | The Role of Disease Activity as a Determinant of Central Sensitivity and Body Awareness in Fibromyalgia Patients: A Cross-Sectional Study |
| title_sort | role of disease activity as a determinant of central sensitivity and body awareness in fibromyalgia patients a cross sectional study |
| topic | body awareness central sensitization fibromyalgia syndrome disease activity |
| url | https://dergipark.org.tr/tr/download/article-file/4144550 |
| work_keys_str_mv | AT yaseminmirza theroleofdiseaseactivityasadeterminantofcentralsensitivityandbodyawarenessinfibromyalgiapatientsacrosssectionalstudy AT ademkucuk theroleofdiseaseactivityasadeterminantofcentralsensitivityandbodyawarenessinfibromyalgiapatientsacrosssectionalstudy AT yaseminmirza roleofdiseaseactivityasadeterminantofcentralsensitivityandbodyawarenessinfibromyalgiapatientsacrosssectionalstudy AT ademkucuk roleofdiseaseactivityasadeterminantofcentralsensitivityandbodyawarenessinfibromyalgiapatientsacrosssectionalstudy |